News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
387,653 Results
Type
Article (26153)
Company Profile (60)
Press Release (361436)
Multimedia
Podcasts (31)
Webinars (7)
Section
Business (104319)
Career Advice (453)
Deals (16877)
Drug Delivery (52)
Drug Development (47660)
Employer Resources (47)
FDA (12311)
Job Trends (8469)
News (186157)
Policy (19501)
Tag
Academia (1752)
Accelerated approval (6)
Adcomms (9)
Allergies (85)
Alliances (26824)
ALS (75)
Alzheimer's disease (892)
Antibody-drug conjugate (ADC) (80)
Approvals (12444)
Artificial intelligence (224)
Autoimmune disease (21)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (51)
Biotechnology (38)
Bladder cancer (87)
Brain cancer (27)
Breast cancer (279)
Cancer (2122)
Cardiovascular disease (178)
Career advice (410)
Career pathing (13)
CAR-T (100)
CDC (24)
Cell therapy (267)
Cervical cancer (19)
Clinical research (41542)
Collaboration (605)
Compensation (210)
Complete response letters (13)
COVID-19 (1531)
CRISPR (26)
C-suite (274)
Cystic fibrosis (50)
Data (2563)
Decentralized trials (2)
Denatured (19)
Depression (55)
Diabetes (257)
Diagnostics (3596)
Digital health (15)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (67)
Drug pricing (74)
Drug shortages (22)
Duchenne muscular dystrophy (86)
Earnings (37871)
Editorial (25)
Employer branding (6)
Employer resources (45)
Events (52887)
Executive appointments (546)
FDA (13905)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (561)
Gene editing (53)
Generative AI (13)
Gene therapy (182)
GLP-1 (478)
Government (3117)
Grass and pollen (3)
Guidances (195)
Healthcare (12198)
HIV (30)
Huntington's disease (13)
IgA nephropathy (28)
Immunology and inflammation (61)
Immuno-oncology (2)
Indications (27)
Infectious disease (1629)
Inflammatory bowel disease (92)
Inflation Reduction Act (5)
Influenza (37)
Intellectual property (79)
Interviews (40)
IPO (7059)
IRA (22)
Job creations (1844)
Job search strategy (380)
Kidney cancer (8)
Labor market (27)
Layoffs (187)
Leadership (5)
Legal (3642)
Liver cancer (62)
Longevity (6)
Lung cancer (354)
Lymphoma (160)
Machine learning (6)
Management (17)
Manufacturing (184)
MASH (75)
Medical device (13090)
Medtech (13101)
Mergers & acquisitions (10215)
Metabolic disorders (602)
Multiple sclerosis (72)
NASH (11)
Neurodegenerative disease (71)
Neuropsychiatric disorders (12)
Neuroscience (1380)
NextGen: Class of 2025 (3931)
Non-profit (2828)
Now hiring (26)
Obesity (268)
Opinion (83)
Ovarian cancer (77)
Pain (98)
Pancreatic cancer (87)
Parkinson's disease (116)
Partnered (13)
Patents (165)
Patient recruitment (188)
Peanut (39)
People (35143)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11893)
Phase II (17974)
Phase III (14765)
Pipeline (1364)
Policy (112)
Postmarket research (1668)
Preclinical (3704)
Press Release (18)
Prostate cancer (119)
Psychedelics (22)
Radiopharmaceuticals (164)
Rare diseases (260)
Real estate (2854)
Recruiting (17)
Regulatory (14803)
Reports (18)
Research institute (1616)
Resumes & cover letters (48)
Rett syndrome (6)
RNA editing (3)
RSV (26)
Schizophrenia (85)
Series A (86)
Series B (71)
Service/supplier (3)
Sickle cell disease (29)
Special edition (6)
Spinal muscular atrophy (103)
Sponsored (15)
Startups (2126)
Stomach cancer (9)
Supply chain (47)
Tariffs (22)
The Weekly (12)
Vaccines (445)
Venture capital (16)
Weight loss (175)
Women's health (23)
Worklife (4)
Date
Today (69)
Last 7 days (229)
Last 30 days (1168)
Last 365 days (17042)
2025 (11841)
2024 (19847)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32192)
2019 (28413)
2018 (21810)
2017 (18905)
2016 (18111)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (360)
Alabama (25)
Alaska (2)
Arizona (135)
Arkansas (10)
Asia (24989)
Australia (3945)
California (4278)
Canada (1586)
China (561)
Colorado (217)
Connecticut (221)
Delaware (172)
Europe (48876)
Florida (742)
Georgia (180)
Idaho (35)
Illinois (459)
India (24)
Indiana (297)
Iowa (7)
Japan (192)
Kansas (82)
Kentucky (16)
Louisiana (12)
Maine (27)
Maryland (757)
Massachusetts (2939)
Michigan (123)
Minnesota (354)
Mississippi (3)
Missouri (61)
Montana (18)
Nebraska (18)
Nevada (52)
New Hampshire (65)
New Jersey (1508)
New Mexico (9)
New York (1242)
North Carolina (676)
North Dakota (4)
Northern California (1904)
Ohio (168)
Oklahoma (6)
Oregon (24)
Pennsylvania (1079)
Puerto Rico (9)
Rhode Island (30)
South America (521)
South Carolina (40)
Southern California (1687)
Tennessee (102)
Texas (769)
United States (17054)
Utah (152)
Virginia (114)
Washington D.C. (47)
Washington State (282)
West Virginia (4)
Wisconsin (49)
387,653 Results for "sequana medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press release: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders
May 23, 2025
·
4 min read
Press Releases
Press release: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025
April 23, 2025
·
4 min read
Press Releases
Press release: CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases
April 14, 2025
·
8 min read
Press Releases
Press release: Sequana Medical announces 2024 Full Year Results and 2025 Outlook
March 18, 2025
·
28 min read
Press Releases
Press release: Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025
March 27, 2025
·
3 min read
Press Releases
Press release: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation
March 20, 2025
·
7 min read
Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024
Sequana Medical NV announces data from its North American pivotal POSEIDON study of the alfapump® demonstrating significantly improved quality of life focused on ascites symptoms and physical functions compared to baseline, which is not seen in refractory ascites patients enrolled contemporaneously in the prospective NACSELD3 cohort.
June 6, 2024
·
8 min read
Business
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces its financial results for the year ended 31 December 2023, and provides a business update and outlook for 2024 and beyond.
March 28, 2024
·
21 min read
Policy
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the agreed outcome of the “Day 100” meetingi with the US Food and Drug Administration, following receipt of the “Day 90” major deficiency Letter.
May 22, 2024
·
8 min read
Press Releases
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares following Loan Conversions
January 24, 2025
·
9 min read
1 of 38,766
Next
